Eric Devroe, the Chief Operating Officer of $ACRV, bought 10,000 shares of the company on 01-13-2026 for an estimated $17,218. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 15.3%. Following this trade, they now own 75,308 shares of this class of $ACRV stock.
$ACRV Insider Trading Activity
$ACRV insiders have traded $ACRV stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ACRV stock by insiders over the last 6 months:
- ERIC DEVROE (Chief Operating Officer) purchased 10,000 shares for an estimated $17,218
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACRV Hedge Fund Activity
We have seen 16 institutional investors add shares of $ACRV stock to their portfolio, and 30 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 682,763 shares (+150057.8%) to their portfolio in Q3 2025, for an estimated $1,235,801
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 382,234 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $691,843
- CITADEL ADVISORS LLC removed 354,193 shares (-18.7%) from their portfolio in Q3 2025, for an estimated $641,089
- HRT FINANCIAL LP removed 145,895 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $264,069
- TWO SIGMA INVESTMENTS, LP added 138,033 shares (+76.2%) to their portfolio in Q3 2025, for an estimated $249,839
- GOLDMAN SACHS GROUP INC removed 120,313 shares (-85.9%) from their portfolio in Q3 2025, for an estimated $217,766
- RENAISSANCE TECHNOLOGIES LLC added 114,105 shares (+22.4%) to their portfolio in Q3 2025, for an estimated $206,530
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACRV Analyst Ratings
Wall Street analysts have issued reports on $ACRV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/25/2025
- Oppenheimer issued a "Outperform" rating on 08/14/2025
To track analyst ratings and price targets for $ACRV, check out Quiver Quantitative's $ACRV forecast page.
$ACRV Price Targets
Multiple analysts have issued price targets for $ACRV recently. We have seen 3 analysts offer price targets for $ACRV in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Edward Tenthoff from Piper Sandler set a target price of $8.0 on 01/09/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $19.0 on 11/25/2025
- Matthew Biegler from Oppenheimer set a target price of $8.0 on 08/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
